Prelude Therapeutics Inc - PRLD - stock price prediction, stock price target, analyst ratings from 3 analysts

Prelude Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of 376.1%, and profit growth estimate of 19.0% for FY26, based on top 3 analyst calls.